William A. Curran
Lawyers
Filters
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
Cabinetworks $100 million new money financing and debt refinancing exchange
We are advising an existing term lender and noteholder on the series of transactions
FMC $252 million sale of FMC India to Crystal Crop Protection
We are advising FMC on the transaction
Cross Country Healthcare sale to Knox Lane
We are advising Cross Country Healthcare on the transaction
Cerberus and Closure Systems International acquisition of compression closure business from Amcor
We advised Cerberus and CSI on the transaction
Cerberus Capital Management strategic investment in S+S Industries
We are advising Cerberus on the transaction
Oruka Therapeutics $700 million follow-on offering
We advised Oruka on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
SMBC MANUBANK sale of its commercial banking unit to Bank of Hope
We are advising SMBC MANUBANK on the transaction